A relentless wave of unpredictability is making Legal’s goal of horizon scanning and mitigating risk increasingly difficult.

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, ...

While there is a new focus on deregulation and simplification for regulators globally, the regulatory landscape is likely to ...

Singapore's utilities firm Sembcorp Industries said on Thursday it has terminated the gas sales deal its unit had signed to ...

Regulatory reforms that improve the competitive landscape for biosimilars will promote drug affordability while incentivizing ...

UK high-end homebuilder Berkeley said on Friday it remained concerned by the impact of the extent and pace of regulatory ...

The Environmental Protection Agency plans more than 30 actions to reconsider rules. They include ones that limit pollution ...

RegFi co-hosts Jerry Buckley and Sherry Safchuk welcome fellow Orrick partner Katy Ryan to discuss the state financial ...

Michigan suspends Conant Driving School for not meeting requirements, including record keeping and curriculum standards.

Novo Nordisk's new obesity drug trial data disappoints again Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate CagriSema ...